BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23750797)

  • 1. Intradermal powder immunization with protein-containing vaccines.
    Weissmueller NT; Schiffter HA; Pollard AJ
    Expert Rev Vaccines; 2013 Jun; 12(6):687-702. PubMed ID: 23750797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal immunization using coated microneedles containing an immunoadjuvant.
    Andrianov AK; Mutwiri G
    Vaccine; 2012 Jun; 30(29):4355-60. PubMed ID: 22682291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle-free epidermal powder immunization.
    Chen D; Maa YF; Haynes JR
    Expert Rev Vaccines; 2002 Oct; 1(3):265-76. PubMed ID: 12901567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous immunization using common chemicals.
    Karande P; Arora A; Pham TK; Stevens D; Wojicki A; Mitragotri S
    J Control Release; 2009 Sep; 138(2):134-40. PubMed ID: 19426770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in dry powder pulmonary vaccine delivery.
    Sou T; Meeusen EN; de Veer M; Morton DA; Kaminskas LM; McIntosh MP
    Trends Biotechnol; 2011 Apr; 29(4):191-8. PubMed ID: 21255854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
    Herzog C
    Expert Rev Vaccines; 2014 Mar; 13(3):399-415. PubMed ID: 24512188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to pediatric vaccine delivery.
    O'Hagan DT; Rappuoli R
    Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
    Safari D; Dekker HA; Rijkers G; Snippe H
    Vaccine; 2011 Jan; 29(4):849-54. PubMed ID: 21111776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle-free vaccine delivery.
    Giudice EL; Campbell JD
    Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser vaccine adjuvant for cutaneous immunization.
    Chen X; Wu MX
    Expert Rev Vaccines; 2011 Oct; 10(10):1397-403. PubMed ID: 21988305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology solutions for mucosal immunization.
    Chadwick S; Kriegel C; Amiji M
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity.
    Chen D; Burger M; Chu Q; Endres R; Zuleger C; Dean H; Payne LG
    Virus Res; 2004 Jul; 103(1-2):147-53. PubMed ID: 15163503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "IDEAL" vaccines for resource poor settings.
    Levine MM
    Vaccine; 2011 Dec; 29 Suppl 4():D116-25. PubMed ID: 22486974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal vaccine delivery systems.
    Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
    Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser vaccine adjuvants. History, progress, and potential.
    Kashiwagi S; Brauns T; Gelfand J; Poznansky MC
    Hum Vaccin Immunother; 2014; 10(7):1892-907. PubMed ID: 25424797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and validation of a skin model for the evaluation of intradermal powder injection devices.
    Deng Y; Winter G; Myschik J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):360-8. PubMed ID: 22484250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.